First name
Okan
Middle name
U
Last name
Elci

Title

Neonatal sepsis registry: Time to antibiotic dataset.

Year of Publication

2019

Number of Pages

104788

Date Published

2019 Dec

ISSN Number

2352-3409

Abstract

<p>This article describes the process of extracting electronic health record (EHR) data into a format that supports analyses related to the timeliness of antibiotic administration. The de-identified data that accompanies this article were collected from a cohort of infants who were evaluated for possible sepsis in the Neonatal Intensive Care Unit (NICU) at the Children's Hospital of Philadelphia (CHOP). The interpretation of findings from these data are reported in a separate manuscript [1]. For purposes of illustration for interested readers, scripts written in the R programming language related to the creation and use of the dataset have also been provided. Interested researchers are encouraged to contact the research team to discuss opportunities for collaboration.</p>

DOI

10.1016/j.dib.2019.104788

Alternate Title

Data Brief

PMID

31799346
Inner Banner
Publication Image
Inner Banner
Publication Image

Title

Surviving Sepsis in a Referral Neonatal Intensive Care Unit: Association between Time to Antibiotic Administration and In-Hospital Outcomes.

Year of Publication

2019

Number of Pages

Date Published

2019 Oct 08

ISSN Number

1097-6833

Abstract

<p><strong>OBJECTIVE: </strong>To determine if time to antibiotic administration is associated with mortality and in-hospital outcomes in a neonatal intensive care unit (NICU) population.</p>

<p><strong>STUDY DESIGN: </strong>We conducted a prospective evaluation of infants with suspected sepsis between September 2014 and February 2018; sepsis was defined as clinical concern prompting blood culture collection and antibiotic administration. Time to antibiotic administration was calculated from time of sepsis identification, defined as the order time of either blood culture or an antibiotic, to time of first antibiotic administration. We used linear models with generalized estimating equations to determine the association between time to antibiotic administration and mortality, ventilator-free and inotrope-free days, and NICU length of stay in patients with culture-proven sepsis.</p>

<p><strong>RESULTS: </strong>Among 1946 sepsis evaluations, we identified 128 episodes of culture-proven sepsis in 113 infants. Among them, prolonged time to antibiotic administration was associated with significantly increased risk of mortality at 14&nbsp;days (OR, 1.47; 95% CI, 1.15-1.87) and 30&nbsp;days (OR, 1.47; 95% CI, 1.11-1.94) as well as fewer inotrope-free days (incidence rate ratio, 0.91; 95% CI, 0.84-0.98). No significant associations with ventilator-free days or NICU length of stay were demonstrated.</p>

<p><strong>CONCLUSIONS: </strong>Among infants with sepsis, delayed time to antibiotic administration was an independent risk factor for death and prolonged cardiovascular dysfunction. Further study is needed to define optimal timing of antimicrobial administration in high-risk NICU populations.</p>

DOI

10.1016/j.jpeds.2019.08.023

Alternate Title

J. Pediatr.

PMID

31604632
Inner Banner
Publication Image
Inner Banner
Publication Image

Title

Hospital Charges for Pediatric Heart Failure-Related Hospitalizations from 2000 to 2009.

Year of Publication

2016

Number of Pages

512-8

Date Published

2016 Mar

ISSN Number

1432-1971

Abstract

<p>Scarce data exist regarding costs of pediatric heart failure-related hospitalizations (HFRH) or how costs have changed over time. Pediatric HFRH costs, due to advances in management, will have increased significantly over time. A retrospective analysis of Healthcare Cost and Utilization Project Kids' Inpatient Database was performed on all pediatric HFRH. Inflation-adjusted charges are used as a proxy for cost. There were a total of 33,189 HFRH captured from 2000 to 2009. Median charges per HFRH rose from $35,079 in 2000 to $72,087 in 2009 (p &lt; 0.0001). The greatest median charges were incurred in patients on extracorporeal membrane oxygenation ($442,134 vs $53,998) or ventricular assist devices ($462,647 vs $55,151). Comorbidities, including sepsis ($207,511 vs $48,995), renal failure ($180,624 vs $52,812), stroke ($198,260 vs $54,974) and respiratory failure ($146,200 vs $48,797), were associated with greater charges (p &lt; 0.0001). Comorbidities and use of mechanical support increased over time. After adjusting for these factors, later year remained associated with greater median charges per HFRH (p &lt; 0.0001). From 2000 to 2009, there has been an almost twofold increase in pediatric HFRH charges, after adjustment for inflation. Although comorbidities and use of mechanical support account for some of this increase, later year remained independently associated with greater charges. Further study is needed to understand potential factors driving these higher costs over time and to identify more cost-effective therapies in this population.</p>

DOI

10.1007/s00246-015-1308-0

Alternate Title

Pediatr Cardiol

PMID

26645995
Inner Banner
Publication Image
Inner Banner
Publication Image